Does Rallies show TELO 10-K and 10-Q filings?

Rallies organizes TELO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is TELO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.

TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - SEC Filings

Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.26 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.28% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find TELO SEC filings?

Rallies organizes TELO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

TELO Key Metrics

Key financial metrics for TELO
Metric	Value
Price	$1.26
Market Cap	$81.84M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$7.08
52-Week Low	$1.05
Volume	65.80K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest TELO News

Telomir-Zn Study Demonstrates Dose-Dependent Survival, Reduced Hepatic Copper Burden — May 20, 2026
Telomir Pharmaceuticals Secures FDA IND Clearance for Telomir-Zn, Plans Phase 1/2 TNBC Trial — Apr 30, 2026
Telomir Secures Worldwide Telomir-1 Rights with $1M Upfront and $4M Milestones — Apr 24, 2026
Telo Genomics Appoints CEO with 3.7M Options; Clinical Results by Summer 2026 — Mar 31, 2026
Telomir-Zn Shows Iron-Dependent Tumor Cell Mortality in Triple-Negative Breast Cancer Models — Feb 17, 2026

Recent TELO Insider Trades

Aminov Erez sold 200 (~$1.20K) on Aug 19, 2024.
Aminov Erez sold 200 (~$1.24K) on Aug 19, 2024.
Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.

TELO Analyst Consensus

TELO analyst coverage data. Average price target: $0.00.

Common questions about TELO

Where can I find TELO SEC filings?: Rallies organizes TELO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TELO 10-K and 10-Q filings?: Rallies organizes TELO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TELO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.